Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance

Introduction: Urinary tract infections (UTIs) are the most commonly encountered infectious diseases. The current study was undertaken with a dual purpose, to provide an insight into the current scenario of the microorganisms causing UTI, their antimicrobial sensitivity patterns and also try and...

Full description

Bibliographic Details
Main Authors: Ekadashi Rajni Sabharwal, Rajni Sharma
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2015-12-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/6951/15227_CE(RA1)_F(T)_PF1(BMAK)_PFA(AK)_PF2(PAG).pdf
id doaj-a096cafd5e714b0bb6ff7fd33532b9c9
record_format Article
spelling doaj-a096cafd5e714b0bb6ff7fd33532b9c92020-11-25T01:19:55ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2015-12-01912DC06DC0910.7860/JCDR/2015/15227.6951Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial ResistanceEkadashi Rajni Sabharwal0Rajni Sharma1Assistant Professor, Department of Microbiology, Ruhs College of Medical Sciences, Jaipur, India.Senior Resident, Department of Microbiology, Ram Manohar Lohia Hospital, New Delhi, India.Introduction: Urinary tract infections (UTIs) are the most commonly encountered infectious diseases. The current study was undertaken with a dual purpose, to provide an insight into the current scenario of the microorganisms causing UTI, their antimicrobial sensitivity patterns and also try and evaluate the activity of fosfomycin against E. coli, both ESBL producers as well as non-producers. Materials and Methods: The study was conducted prospectively in the Department of Microbiology of a tertiary care hospital from January to June 2014. A total of 358 isolates from the urinary samples of the patients with a diagnosis of urinary tract infection were included in the study. Antibiotic sensitivity testing and extended spectrum beta lactamase (ESBL) production testing was done as per CLSI guidelines. Results: These represented 297 (82.9%) gram-negative isolates and 61 (17%) gram-positive isolates. The 297 gramnegative isolates represented 265 (89.2%) members of the Enterobacteriaceae, 185 (69.8%) of which were Escherichia coli, 66 (24.9%) Klebsiella spp. and 14 (5.28%) Proteus spp. Nonfermentative Pseudomonas spp were isolated from 8.9% cases. Amongst the Gram negative isolates tested, 78 (21.8%) formed extended spectrum beta-lactamases. Of the total 358 isolates tested, 338 (94.4%) were found to be susceptible to fosfomycin. Conclusion: Fosfomycin showed good activity against both ESBL-producing and ESBL-negative E. coli isolates. The main finding of our study is that fosfomycin exhibits excellent antimicrobial activity even against the isolates with relatively high levels of antimicrobial resistance and hence can be a useful drug in our armamentarium.https://jcdr.net/articles/PDF/6951/15227_CE(RA1)_F(T)_PF1(BMAK)_PFA(AK)_PF2(PAG).pdfantimicrobial agentsantimicrobial sensitivityextended spectrum beta lactamase (esbl)
collection DOAJ
language English
format Article
sources DOAJ
author Ekadashi Rajni Sabharwal
Rajni Sharma
spellingShingle Ekadashi Rajni Sabharwal
Rajni Sharma
Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance
Journal of Clinical and Diagnostic Research
antimicrobial agents
antimicrobial sensitivity
extended spectrum beta lactamase (esbl)
author_facet Ekadashi Rajni Sabharwal
Rajni Sharma
author_sort Ekadashi Rajni Sabharwal
title Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance
title_short Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance
title_full Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance
title_fullStr Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance
title_full_unstemmed Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance
title_sort fosfomycin: an alternative therapy for the treatment of uti amidst escalating antimicrobial resistance
publisher JCDR Research and Publications Private Limited
series Journal of Clinical and Diagnostic Research
issn 2249-782X
0973-709X
publishDate 2015-12-01
description Introduction: Urinary tract infections (UTIs) are the most commonly encountered infectious diseases. The current study was undertaken with a dual purpose, to provide an insight into the current scenario of the microorganisms causing UTI, their antimicrobial sensitivity patterns and also try and evaluate the activity of fosfomycin against E. coli, both ESBL producers as well as non-producers. Materials and Methods: The study was conducted prospectively in the Department of Microbiology of a tertiary care hospital from January to June 2014. A total of 358 isolates from the urinary samples of the patients with a diagnosis of urinary tract infection were included in the study. Antibiotic sensitivity testing and extended spectrum beta lactamase (ESBL) production testing was done as per CLSI guidelines. Results: These represented 297 (82.9%) gram-negative isolates and 61 (17%) gram-positive isolates. The 297 gramnegative isolates represented 265 (89.2%) members of the Enterobacteriaceae, 185 (69.8%) of which were Escherichia coli, 66 (24.9%) Klebsiella spp. and 14 (5.28%) Proteus spp. Nonfermentative Pseudomonas spp were isolated from 8.9% cases. Amongst the Gram negative isolates tested, 78 (21.8%) formed extended spectrum beta-lactamases. Of the total 358 isolates tested, 338 (94.4%) were found to be susceptible to fosfomycin. Conclusion: Fosfomycin showed good activity against both ESBL-producing and ESBL-negative E. coli isolates. The main finding of our study is that fosfomycin exhibits excellent antimicrobial activity even against the isolates with relatively high levels of antimicrobial resistance and hence can be a useful drug in our armamentarium.
topic antimicrobial agents
antimicrobial sensitivity
extended spectrum beta lactamase (esbl)
url https://jcdr.net/articles/PDF/6951/15227_CE(RA1)_F(T)_PF1(BMAK)_PFA(AK)_PF2(PAG).pdf
work_keys_str_mv AT ekadashirajnisabharwal fosfomycinanalternativetherapyforthetreatmentofutiamidstescalatingantimicrobialresistance
AT rajnisharma fosfomycinanalternativetherapyforthetreatmentofutiamidstescalatingantimicrobialresistance
_version_ 1725136573591191552